Clinical Trial: AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: B-cell Acute Lymphoblastic Leukemia (B-ALL)
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Study to Evaluate the Safety and Efficacy of AZD0486 in Adolescent and Adult Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia
Brief Summary:
This is a Phase 1/2, global multicentre, open-label, single-arm, dose escalation and dose optimisation study of AZD0486 to evaluate the safety, tolerability, and efficacy of AZD0486 monotherapy in participants with R/R B ALL who have received ? 2 prior lines of therapies.The study will consist of 3 parts.Part A monotherapy dose escalation.Part B dose optimisation.Part C Dose expansion at the recommended phase 2 dose (RP2D)
Read more